shRNA Silencing of AS3MT Expression Minimizes Arsenic Methylation Capacity of HepG2 Cells
- 28 June 2006
- journal article
- research article
- Published by American Chemical Society (ACS) in Chemical Research in Toxicology
- Vol. 19 (7) , 894-898
- https://doi.org/10.1021/tx060076u
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Dicing and slicingFEBS Letters, 2005
- Small RNA asymmetry in RNAi: Function in RISC assembly and gene regulationFEBS Letters, 2005
- RNAi: The Nuts and Bolts of the RISC MachineCell, 2005
- The Glycolytic Enzyme Glyceraldehyde-3-Phosphate Dehydrogenase Works as an Arsenate Reductase in Human Red Blood Cells and Rat Liver CytosolToxicological Sciences, 2005
- Distributions and chemical forms of arsenic after intravenous administration of dimethylarsinic and monomethylarsonic acids to ratsToxicology and Applied Pharmacology, 2004
- Endogenous Reductants Support the Catalytic Function of Recombinant Rat Cyt19, an Arsenic MethyltransferaseChemical Research in Toxicology, 2004
- Selenium Compounds Modulate the Activity of Recombinant Rat AsIII-Methyltransferase and the Methylation of Arsenite by Rat and Human HepatocytesChemical Research in Toxicology, 2003
- Human Monomethylarsonic Acid (MMAV) Reductase Is a Member of the Glutathione-S-transferase SuperfamilyChemical Research in Toxicology, 2001
- Enzymatic Reduction of Arsenic Compounds in Mammalian Systems: The Rate-Limiting Enzyme of Rabbit Liver Arsenic Biotransformation Is MMAV ReductaseChemical Research in Toxicology, 1999
- Enzymic Methylation of Arsenic Compounds: Assay, Partial Purification, and Properties of Arsenite Methyltransferase and Monomethylarsonic Acid Methyltransferase of Rabbit LiverChemical Research in Toxicology, 1995